[go: up one dir, main page]

GB9821000D0 - Antiviral combinations - Google Patents

Antiviral combinations

Info

Publication number
GB9821000D0
GB9821000D0 GBGB9821000.8A GB9821000A GB9821000D0 GB 9821000 D0 GB9821000 D0 GB 9821000D0 GB 9821000 A GB9821000 A GB 9821000A GB 9821000 D0 GB9821000 D0 GB 9821000D0
Authority
GB
United Kingdom
Prior art keywords
antiviral combinations
antiviral
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9821000.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9821000.8A priority Critical patent/GB9821000D0/en
Publication of GB9821000D0 publication Critical patent/GB9821000D0/en
Priority to PCT/EP1999/007132 priority patent/WO2000018383A2/en
Priority to AU61967/99A priority patent/AU6196799A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9821000.8A 1998-09-28 1998-09-28 Antiviral combinations Ceased GB9821000D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9821000.8A GB9821000D0 (en) 1998-09-28 1998-09-28 Antiviral combinations
PCT/EP1999/007132 WO2000018383A2 (en) 1998-09-28 1999-09-27 Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester
AU61967/99A AU6196799A (en) 1998-09-28 1999-09-27 Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h-quinoxaline-1- carboxylic acid isopropyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9821000.8A GB9821000D0 (en) 1998-09-28 1998-09-28 Antiviral combinations

Publications (1)

Publication Number Publication Date
GB9821000D0 true GB9821000D0 (en) 1998-11-18

Family

ID=10839534

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9821000.8A Ceased GB9821000D0 (en) 1998-09-28 1998-09-28 Antiviral combinations

Country Status (3)

Country Link
AU (1) AU6196799A (en)
GB (1) GB9821000D0 (en)
WO (1) WO2000018383A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286716T3 (en) * 2003-10-01 2007-12-01 Lupin Limited PHARMACEUTICAL COMPOSITION OF CONTROLLED LIBERATION AND PROCESS TO PREPARE THE SAME.
US8481554B2 (en) 2009-05-27 2013-07-09 Hetero Research Foundation Solid oral dosage forms of lamivudine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342024A1 (en) * 1993-12-09 1995-06-14 Hoechst Ag Combination preparations containing a quinoxaline and a nucleoside
DE19703131A1 (en) * 1997-01-29 1998-07-30 Bayer Ag Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Also Published As

Publication number Publication date
AU6196799A (en) 2000-04-17
WO2000018383A2 (en) 2000-04-06
WO2000018383A3 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
GB9815567D0 (en) Antiviral compound
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
GB9807354D0 (en) Antiviral compound
DE59903023D1 (en) Perorale wirkstoff-suspension
GB9804469D0 (en) Antiviral composition
DE59914151D1 (en) Arylalkanoylpyridazine
DE60042897D1 (en) Photovervielfacherröhre
ZA984083B (en) Antiviral combinations.
GB9820420D0 (en) Antiviral combinations
DE59904407D1 (en) Chromanderivate
PL341819A1 (en) Antiviral agents
GB9807355D0 (en) Antiviral compound
DE59900495D1 (en) Multimetalloxidmassen
GB9808496D0 (en) Resistance-monitoring arrangement
HUP0105165A3 (en) Lichting arrangement
DE59900471D1 (en) Inchbremseinrichtung
GB9820417D0 (en) Antiviral combinations
ZA975565B (en) Antiviral combinations
HUP9903242A2 (en) Special adhesive-bond
GB9821000D0 (en) Antiviral combinations
DE59905941D1 (en) Methoximinophenylessigsäureamide
GB9820416D0 (en) Antiviral combinations
DE59911094D1 (en) Tryptase-inhibitoren
GB9827109D0 (en) Antiviral combinations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)